Summan Amit, Nandi Arindam, Shet Anita, Laxminarayan Ramanan
One Health Trust, Washington, DC, USA.
The Population Council, 1 Dag Hammarskjold Plaza, New York, NY, 10017, USA.
Lancet Reg Health Southeast Asia. 2023 Jan;8:100099. doi: 10.1016/j.lansea.2022.100099. Epub 2022 Oct 21.
The COVID-19 pandemic has disrupted health systems globally. We estimated the effect of the pandemic on the coverage and timeliness of routine childhood immunization in India through April 2021.
We used data from India's National Family Health Survey 2019-2021 (NFHS-5), a cross-sectional survey which collected immunization information of under-five children from a nationally representative sample of households between June 2019 and April 2021. We used a mother fixed-effects regression model - accounting for secular trends and confounding factors - to compare COVID-affected children with their COVID-unaffected siblings (n = 59,144). Children who were eligible for a vaccine after January 30, 2020 (date of the first COVID case in India) were considered as the COVID-affected group and those eligible for a vaccine before this date were included in the COVID-unaffected group. Coverage of the following vaccine doses was considered-Bacillus Calmette-Guérin (BCG), hepatitis B birth dose (hepB0), DPT1 (diphtheria, pertussis, and tetanus, first dose), DPT2, DPT3, polio1, polio2, polio3, and measles first dose (MCV1). Indicators of vaccine coverage and vaccine timeliness (defined as receiving a dose within 45 days of minimum eligibility age) were separately examined.
Immunization coverage was lower in COVID-affected children as compared with unaffected children, ranging from 2% lower for BCG and hepB0 to 9% for DPT3 and 10% for polio3. There was no significant difference in MCV1 coverage. Coverage reduction was greater for vaccines doses given in later age groups. The rate of timely receipt of polio and DPT vaccine doses was 3%-5% lower among COVID-affected children relative to unaffected children. Among population subgroups, COVID-affected male children and those from rural areas experienced the highest reduction in vaccine coverage.
Children in India experienced lower routine immunization coverage and greater delays in immunization during the COVID-19 pandemic.
The Bill & Melinda Gates Foundation.
新冠疫情扰乱了全球卫生系统。我们评估了截至2021年4月该疫情对印度儿童常规免疫接种覆盖率和及时性的影响。
我们使用了印度2019 - 2021年全国家庭健康调查(NFHS - 5)的数据,这是一项横断面调查,于2019年6月至2021年4月期间从全国具有代表性的家庭样本中收集了五岁以下儿童的免疫接种信息。我们使用了母亲固定效应回归模型——考虑到长期趋势和混杂因素——将受新冠影响的儿童与其未受新冠影响的兄弟姐妹(n = 59,144)进行比较。2020年1月30日(印度首例新冠病例日期)之后有资格接种疫苗的儿童被视为受新冠影响组,在此日期之前有资格接种疫苗的儿童被纳入未受新冠影响组。考虑了以下疫苗剂量的覆盖率——卡介苗(BCG)、乙肝出生剂量(hepB0)、百白破第一剂(DPT1,即白喉、百日咳和破伤风第一剂)、百白破第二剂、百白破第三剂、脊髓灰质炎第一剂、脊髓灰质炎第二剂、脊髓灰质炎第三剂以及麻疹第一剂(MCV1)。分别检查了疫苗覆盖率和疫苗及时性指标(定义为在最低合格年龄后45天内接种一剂)。
与未受影响的儿童相比,受新冠影响的儿童免疫接种覆盖率较低,卡介苗和乙肝出生剂量低2%,百白破第三剂低9%,脊髓灰质炎第三剂低10%。麻疹第一剂覆盖率没有显著差异。年龄较大组接种的疫苗剂量覆盖率下降幅度更大。受新冠影响的儿童中,脊髓灰质炎和百白破疫苗剂量的及时接种率比未受影响的儿童低3% - 5%。在人群亚组中,受新冠影响的男童和农村地区儿童的疫苗覆盖率下降幅度最大。
在新冠疫情期间,印度儿童的常规免疫接种覆盖率较低,免疫接种延迟情况更严重。
比尔及梅琳达·盖茨基金会。